Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$227,123,448
+$187,977,623 QoQ
Shares Held
2,003,559
+381.7% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#18
of 854 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. INCY ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
This page
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in INCY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,123,448 | 2,003,559 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,145,825 | 415,914 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,629,698 | 36,749 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,083,516 | 48,149 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,382,166 | 64,349 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,450,441 | 56,985 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,937,344 | 28,049 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,360,602 | 20,584 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,220,191 | 218,083 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $60,074,181 | 1,054,488 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $120,041,105 | 1,911,787 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $94,955,913 | 1,643,689 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $131,015,956 | 2,104,674 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,735,780 | 591,335 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,573,551 | 393,097 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,031,586 | 60,498 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $28,876,121 | 380,099 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $44,338,994 | 558,285 | Shares | Sole | 2022-05-16 | |
| 2020-12-31 | $1,405,857 | 16,163 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $16,170,340 | 180,191 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,690,693 | 54,734 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $11,019,357 | 150,476 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||